An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable

Revista da Sociedade Brasileira de Medicina Tropical

Manoel Paes De Oliveira-neto¹  Marise Da Silva Mattos¹ 

[1] ,Fundação Oswaldo Cruz Instituto de Pesquisas Clínicas Evandro Chagas Ambulatório de LeishmanioseRio de Janeiro RJ

关键词: Cutaneous leishmaniasis;    Pentavalent antimony;    Low dose;    Systemic therapy;    Leishmaniose cutânea;    Antimônio pentavalente;    Baixa dose;    Tratamento sistêmico;   

DOI  :  10.1590/S0037-86822006000400001

来源: SciELO

【 摘 要 】

Despite more than half a century of use in leishmaniasis, antimony therapy still presents serious problems concerning dosage and toxicity. Low and high doses have been shown to be equally effective. In this paper, the feasibility of injecting one ampoule of meglumine antimoniate intramuscularly every other day until clinical cure is demonstrated, while studying a series of 40 cutaneous leishmaniasis cases. Total dose used varied from 1,822.5 to 12,150mg of pentavalent antimony and total time of treatment varied from 3 to 10 weeks, with 86% efficacy. Thirty-six out of the 40 patients are still on follow-up with a mean time of 10.7 ± 7 months and a median of 9 months. No relapse or mucosal lesions have been noted so far. The schedule showed good tolerance and easy application and its efficacy was comparable to the officially recommended WHO schedule. Therefore, such a schedule represents a valuable alternative for the cases with high toxicicity to antimony or daily injections are an obstacle to the treatment.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License